enVVeno Medical Corp Cash and Cash Equivalents
enVVeno Medical Corp (NVNO) had Cash and Cash Equivalents of $2.84 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-30
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.84M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $2.60M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.06M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.54M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $2.84M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $2.60M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $3.06M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $1.54M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $2.04M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $2.94M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $1.75M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $17.91M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $2.38M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $2.31M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.62M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $4.95M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $4.71M 10-Q · filed 2023-07-31 | |
| 2023-03-31 | $2.27M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $4.55M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $2.90M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $9.07M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $51.34M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $54.73M 10-K · filed 2023-03-02 | $54.73M 10-K · filed 2022-03-28 |
| 2021-09-30 | $57.90M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $41.04M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $43.84M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $9.33M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $5.63M 10-Q · filed 2020-11-17 | |
| 2020-06-30 | $1.56M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $720.13K 10-Q · filed 2020-06-08 | |
| 2019-12-31 | $1.31M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $2.94M 10-Q · filed 2020-11-17 | |
| 2019-06-30 | $4.47M 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $2.75M 10-Q · filed 2020-06-08 | |
| 2018-12-31 | $2.74M 10-K · filed 2020-03-18 | |
| 2018-09-30 | $4.19M 10-Q · filed 2018-11-07 | |
| 2018-03-31 | $309.13K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $77.69K 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $311.48K 10-Q · filed 2018-11-07 | |
| 2016-12-31 | $56.51K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |